Posted by Michael Wonder on 11 Nov 2021
Three cancer drugs approved for NHS use in Scotland
10 November 2021 - Three new cancer drugs have been given the go-ahead by the SMC for routine use in Scotland, but a fourth has been rejected.
The approved drugs are:
- Atezolizumab (Tecentriq) for adults with non small cell lung cancer that has spread to another part of their body;
- Osimertinib (Tagrisso) for adults whose non small cell lung cancer tests positive for a faulty version of a molecule called EGFR;
- Pembrolizumab (Keytruda) for patients aged 3 years or older with classical Hodgkin lymphoma, a cancer of the white blood cells, that has come back or doesn’t respond to treatment.
